LEP and cancer: Both metabolic dysfunction and cancer are characterized by changes in circulating factors, such as fibroblast growth factor 21 (FGF21 [28]), growth differentiating factor 15 (GDF‐15 [29]), leptin [20] and inflammatory cytokines [30].